Charles Lawrence Cywin

This inventor holds 18 USPTO granted patents, primarily in Heterocyclic Compounds. Top assignees: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 1998-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles Lawrence Cywin. Retrieved from https://idiyas.com/inventor/charles-lawrence-cywin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 10

Forward Citations = 442(Granted Patents)

Company Filing History:

18 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

1 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

where one patent can have more than one assignee

Years Active: 1998-2010

Loading Chart...

Areas of Expertise:

Heterocycles

Inhibitors

SYK Kinase

PKC-Theta

Anti-Inflammatory

Benzimidazole

Thieno-Pyridine

Naphthyridines

Reversible Inhibitors

Aromatic Compounds

Pyrazoles

Nitrile Compounds

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7705151 - 1,6 Naphthridines useful as inhibitors of SYK kinase (2010-04-27),

2. 7678911 - 1,6 naphthyridines useful as inhibitors of SYK kinase (2010-03-16),

3. 7550473 - Pyrimidine derivatives useful as inhibitors of PKC-theta (2009-06-23),

4. 7405225 - Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses (2008-07-29),

5. 7321041 - 1,6 Naphthyridines useful as inhibitors of SYK kinase (2008-01-22),

6. 7291733 - Substituted tricyclic heterocycles and their uses (2007-11-06),

7. 7138420 - Substituted benzimidazole compounds (2006-11-21),

8. 6974870 - Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses (2005-12-13),

9. 6964956 - Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses (2005-11-15),

10. 6825219 - Substituted benzimidazole compounds (2004-11-30),

11. 6730671 - Compounds useful as reversible inhibitors of cathespin S (2004-05-04),

12. 6608057 - Compounds useful as reversible inhibitors of cathepsin S (2003-08-19),

13. 6506747 - Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents (2003-01-14),

14. 6395897 - Nitrile compounds useful as reversible inhibitors of &num;9 cathepsin 5 (2002-05-28),

15. 6228881 - Aromatic heterocyclic compounds and their use as anti-inflammatory agents (2001-05-08),

Title: The Innovative Journey of Charles Lawrence Cywin

Introduction: Charles Lawrence Cywin, a talented inventor hailing from Bethel, CT (US), has made significant contributions to the field of innovations with his creative mind and dedication to problem-solving.

Latest Patents: Charles Lawrence Cywin holds several patents in various industries, showcasing his versatility and ingenuity in inventing new solutions to existing challenges.

Career Highlights: Throughout his career, Charles Lawrence Cywin has demonstrated a keen ability to identify gaps in the market and develop groundbreaking inventions to fill those voids. His passion for innovation has led to the creation of several successful products that have improved the lives of many.

Collaborations: Charles Lawrence Cywin has collaborated with leading companies, research institutions, and universities to bring his inventions to life. These partnerships have allowed him to leverage the expertise of others and bring his ideas to fruition on a larger scale.

Conclusion: In conclusion, Charles Lawrence Cywin stands as a shining example of an inventor who has made a lasting impact on the world of innovations. His dedication to pushing the boundaries of what is possible has solidified his place as a respected figure in the industry.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]